BOYDSense

Description

BOYDSense develops non-invasive, pain-free health monitoring technology and devices for multi-condition detection and monitoring, with an initial application in diabetes and glucose monitoring for healthcare providers and patients.

BOYDSense is located in the Toulouse ecosystem.

Related

• DiabeloopDiabeloop develops automated, personalized insulin delivery software powered by artificial intelligence, using compatible continuous…
• Bluedrop MedicalBluedrop Medical builds an at-home foot-health scanning system (OneStep Foot Scanner) and monitoring service to detect early diabetic foot…
• CroíValveCroíValve develops the DUO Adapt™ System, a minimally invasive transcatheter heart valve device for treating tricuspid regurgitation in…
• GratXrayGratXray develops breast cancer imaging technology, including senoa breast CT, combining scientific work with safer, more reliable,…
• Nimble DiagnosticsNimble Diagnostics develops a non-invasive, portable monitoring device that detects stent complications, measuring stent malfunction with…
• Neurent MedicalNeurent Medical develops the NEUROMARK System, a radiofrequency-based ENT medical device that targets posterior nasal nerves to provide…
• DebiopharmDebiopharm develops and manufactures pharmaceutical drugs and invests in digital health, focusing on oncology and bacterial infections and…
• Jazz PharmaceuticalsJazz Pharmaceuticals develops and commercializes medicines for people with rare diseases, focusing on therapies for epilepsies, cancers and…
• LEO PharmaLEO Pharma develops and delivers innovative treatments for medical dermatology, producing medicines and supplying healthcare providers and…